The Journal of Practical Medicine >
Research progress of the mechanisms of fatigue in Long COVID patients
Received date: 2023-11-21
Online published: 2024-05-15
Since COVID?19 infection， many infected patients have developed multiple systemic symptoms that persist long after 3 months of infection， which is called Long COVID. Numerous studies have shown that fatigue is the most common symptom among the many symptoms of Long COVID that has severely impacted the quality of their life. Therefore， it is particularly important to understand the mechanisms by which Long COVID causes fatigue symptoms. This article summarizes the possible mechanisms of Long COVID fatigue， including immune response， oxidative stress， and affecting the central nervous system， by combing through the relevant literature， aiming to increase clinical awareness of fatigue induced by Long COVID and to provide certain ideas for its treatment.
Key words： Long COVID; fatigue; mechanisms
Qiaoyan GUAN , Songyu BAO , Yuanyuan CUI , Siming. LI . Research progress of the mechanisms of fatigue in Long COVID patients[J]. The Journal of Practical Medicine, 2024 , 40(9) : 1186 -1190 . DOI: 10.3969/j.issn.1006-5725.2024.09.002
| 1 | LAI C C， HSU C K， YEN M Y， et al. Long COVID： An inevitable sequela of SARS-CoV-2 infection ［J］. J Microbiol Immunol Infect， 2023，56（1）：1-9. doi:10.1016/j.jmii.2022.10.003 |
| 2 | FERNANDEZ-ED-LAS-PENAS C. Long COVID： current definition［J］. Infection， 2022，50（1）：285-286. doi:10.1007/s15010-021-01696-5 |
| 3 | 栾涛，杨罡，王帅颖，等. “长新冠”综合征研究最新进展［J］. 实用医学杂志， 2023，39（10）：1195-1200. |
| 4 | National Institute for Health and Care Excellence. COVID-19 rapid guideline：managing the long-term effects of COVID-19 NICE guideline［EB/OL］. （2021-11-11）［2022-05-30］.. |
| 5 | DATTA S D， TALWAR A， LEE J T. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection： Illness Beyond Acute Infection and Public Health Implications［J］. JAMA， 2020，324（22）：2251-2252. doi:10.1001/jama.2020.22717 |
| 6 | SORIANO J B， MURTHY S， MARSHALL J C， et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus［J］. Lancet Infect Dis， 2022，22（4）：e102-e107. doi:10.1016/s1473-3099(21)00703-9 |
| 7 | CEBAN F， LING S， LUI L M W， et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome： A systematic review and meta-analysis［J］. Brain Behav Immun， 2022，101：93-135. doi:10.1016/j.bbi.2021.12.020 |
| 8 | MICHELEN M， MANOHARAN L， ELKHEIR N， et al. Characterising long COVID： a living systematic review［J］. BMJ Glob Health， 2021，6（9）：e005427. doi:10.1136/bmjgh-2021-005427 |
| 9 | HUANG C， HUANG L， WANG Y， et al. 6-month consequences of COVID-19 in patients discharged from hospital： a cohort study［J］. Lancet， 2021，397（10270）：220-232. doi:10.1016/s0140-6736(20)32656-8 |
| 10 | GOERTZ Y M J， VAN HERCK M， DELBRESSINE J M， et al. Persistent symptoms 3?months after a SARS-CoV-2 infection： the post-COVID-19 syndrome？［J］. ERJ Open Res， 2020，6（4）：00542-2020. doi:10.1183/23120541.00542-2020 |
| 11 | KOVARIK J J， BILECK A， HAGN G， et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome［J］. iScience， 2023，26（1）：105717. doi:10.1016/j.isci.2022.105717 |
| 12 | AKGUN A， SEN A， ONAL H. Clinical， biochemical and genotypical characteristics in biotinidase deficiency［J］. J Pediatr Endocrinol Metab， 2021，34（11）：1425-1433. doi:10.1515/jpem-2021-0242 |
| 13 | FU Y J， XU B， HUANG S W， et al. Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14［J］. Acta Pharmacol Sin， 2021，42（1）：88-96. doi:10.1038/s41401-020-0411-9 |
| 14 | KAWANO A， ARIYOSHI W， YOSHIOKA Y， et al. Docosahexaenoic acid enhances M2 macrophage polarization via the p38 signaling pathway and autophagy［J］. J Cell Biochem， 2019，120（8）：12604-12617. doi:10.1002/jcb.28527 |
| 15 | PROAL A D， VANELZAKKER M B. Long COVID or Post-acute Sequelae of COVID-19 （PASC）： An Overview of Biological Factors That May Contribute to Persistent Symptoms［J］. Front Microbiol， 2021，12：698169. doi:10.3389/fmicb.2021.698169 |
| 16 | DEBNATH S， LORENZO C， BANSAL S， et al. Branched-Chain Amino Acids Depletion during Hemodialysis Is Associated with Fatigue［J］. Am J Nephrol， 2020，51（7）：565-571. doi:10.1159/000507839 |
| 17 | ABUMOH'D M F， MATALQAH L， AL-ABDULLA Z. Effects of Oral Branched-Chain Amino Acids （BCAAs） Intake on Muscular and Central Fatigue During an Incremental Exercise［J］. J Hum Kinet， 2020，72：69-78. doi:10.2478/hukin-2019-0099 |
| 18 | ZHANG F， WAN Y， ZUO T， et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19［J］. Gastroenterology， 2022，162（2）：548-561.e4. doi:10.1053/j.gastro.2021.10.013 |
| 19 | SHEN B， YI X， SUN Y， et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera［J］. Cell， 2020，182（1）：59-72.e15. doi:10.1016/j.cell.2020.05.032 |
| 20 | WONG T L， WEITZER D J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome （ME/CFS）-A Systemic Review and Comparison of Clinical Presentation and Symptomatology［J］. Medicina （Kaunas）， 2021，57（5）：418. doi:10.3390/medicina57050418 |
| 21 | NOOR N， URITS I， DEGUEURE A， et al. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome［J］. Anesth Pain Med， 2021，11（3）：e113629. doi:10.5812/aapm.113629 |
| 22 | TOMAS C， ELSON J L， STRASSHEIM V， et al. The effect of myalgic encephalomyelitis/chronic fatigue syndrome （ME/CFS） severity on cellular bioenergetic function［J］. PLoS One， 2020，15（4）：e0231136. doi:10.1371/journal.pone.0231136 |
| 23 | CHEN T H， CHANG C J， HUNG P H. Possible Pathogenesis and Prevention of Long COVID： SARS-CoV-2-Induced Mitochondrial Disorder［J］. Int J Mol Sci， 2023，24（9）：8034. doi:10.3390/ijms24098034 |
| 24 | NUNN A V W， GUY G W， BRYSCH W， et al. Understanding Long COVID； Mitochondrial Health and Adaptation-Old Pathways， New Problems［J］. Biomedicines， 2022，10（12）：3113. doi:10.3390/biomedicines10123113 |
| 25 | WOOD E， HALL K H， TATE W. Role of mitochondria， oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome： A possible approach to SARS-CoV-2 'long-haulers'？ ［J］. Chronic Dis Transl Med， 2021，7（1）：14-26. doi:10.1016/j.cdtm.2020.11.002 |
| 26 | VOLLBRACHT C， KRAFT K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID： Implications for the Benefit of High-Dose Intravenous Vitamin C［J］. Front Pharmacol， 2022，13：899198. doi:10.3389/fphar.2022.899198 |
| 27 | RASMUSSEN M K， MESTRE H， NEDERGAARD M. Fluid transport in the brain［J］. Physiol Rev， 2022，102（2）：1025-1151. doi:10.1152/physrev.00031.2020 |
| 28 | WOSTYN P. COVID-19 and chronic fatigue syndrome： Is the worst yet to come？ ［J］. Med Hypotheses， 2021，146：110469. doi:10.1016/j.mehy.2020.110469 |
| 29 | BRAGEE B， MICHOS A， DRUM B， et al. Signs of Intracranial Hypertension， Hypermobility， and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome［J］. Front Neurol， 2020，11：828. doi:10.3389/fneur.2020.00828 |
| 30 | TAY M Z， POH C M， RENIA L， et al. The trinity of COVID-19： immunity， inflammation and intervention［J］. Nat Rev Immunol， 2020，20（6）：363-374. doi:10.1038/s41577-020-0311-8 |
| 31 | RODRIGUEZ M， SOLER Y， PERRY M， et al. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 （SARS-CoV-2） in the Nervous System： Implications of COVID-19 in Neurodegeneration［J］. Front Neurol， 2020，11：583459. doi:10.3389/fneur.2020.583459 |
| 32 | GUEDJ E， CAMPION J Y， DUDOUET P， et al. 18F-FDG brain PET hypometabolism in patients with long COVID［J］. Eur J Nucl Med Mol Imaging， 2021，48（9）：2823-2833. doi:10.1007/s00259-021-05215-4 |
| 33 | HAFIZ R， GANDHI T K， MISHRA S， et al. Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue［J］. Neuroimage Rep， 2022，2（2）：100095. doi:10.1016/j.ynirp.2022.100095 |
| 34 | MARGALIT I， YELIN D， SAGI M， et al. Risk Factors and Multidimensional Assessment of Long Coronavirus Disease Fatigue： A Nested Case-Control Study［J］. Clin Infect Dis， 2022，75（10）：1688-1697. doi:10.1093/cid/ciac283 |
| 35 | FERRANDI P J， ALWAY S E， MOHAMED J S. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies［J］. J Appl Physiol （1985）， 2020，129（4）：864-867. doi:10.1152/japplphysiol.00321.2020 |
| 36 | RUDROFF T， FIETSAM A C， DETERS J R， et al. Post-COVID-19 Fatigue： Potential Contributing Factors［J］. Brain Sci， 2020，10（12）：1012. doi:10.3390/brainsci10121012 |
| 37 | 李辉雁，吴虹林，匡铭，等. 后疫情时代新型冠状病毒肺炎局部暴发防控期间医学研究生心理健康状况调查［J］. 实用医学杂志， 2021，37（23）：3067-3071. doi:10.3969/j.issn.1006-5725.2021.23.021 |
| 38 | RATHI A， JADHAV S B， SHAH N. A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue［J］. Medicines （Basel）， 2021，8（9）：47. doi:10.3390/medicines8090047 |
| 39 | TOSATO M， CALVANI R， PICCA A， et al. Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance， Endothelial Function， and Persistent Fatigue in Adults with Long COVID： A Single-Blind Randomized Controlled Trial［J］. Nutrients， 2022，14（23）：4984. doi:10.3390/nu14234984 |
| 40 | 牛佳牧，刘嘉玮，林慧娇，等. 五味子酸性多糖对小鼠抗疲劳作用的实验研究［J］. 北华大学学报（自然科学版）， 2020，21（6）：730-733. |
| 41 | 陈春苗，田友清，丁平，等. 当归多肽抗慢性疲劳效应的实验研究［J］. 中医药导报， 2023，29（3）：43-48. |
| 42 | JIMENO-ALMAZAN A， FRANCO-LOPEZ F， BUENDIA- ROMERO á， et al. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention： A randomized controlled trial［J］. Scand J Med Sci Sports， 2022，32（12）：1791-1801. doi:10.1111/sms.14240 |
| 43 | 解有成，康殷楠，李初谊，等. 数字疗法在新型冠状病毒肺炎后遗症中的应用［J］. 实用医学杂志，2022，38（21）：2635-2638. doi:10.3969/j.issn.1006-5725.2022.21.001 |
/
| 〈 |
|
〉 |